The test, which looks for cell damage associated with the disease, is years away from being commercially available. If its reliability is confirmed in future trials, the test would allow doctors to diagnose the condition earlier and start therapies sooner, before nervous system damage worsens, the researchers said.
This news item came from: https://www.canberratimes.com.au/story/8330234/blood-test-for-parkinsons-is-promising-in-early-study/
